Write to Karl Loren -- he will answer
The Number One Selling Drug In America -- Lipitor -- A Fraud Based On Fraud
The Nobel Prize in Physiology or Medicine 1985
More than two decades of Nobel Prize winners in medicine
The Number One Selling Drug In America -- Lipitor -- A Fraud Based On Fraud
[Karl Note: Here is the most worthless fraud on the American scene. Lipitor, the number one selling drug, supposedly reduces your cholesterol rate, but the truth is that lowering that rate does NOT reduce death from heart disease.
Why do people take it?
Because corrupt doctors prescribe it.
 |
 |
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
| Ask your doctor if Lipitor, the #1 prescribed
cholesterol-lowering medicine, is right for you. It could make a
difference. Lipitor is the #1 prescribed cholesterol-lowering drug in the United States. Over 18 million Americans have been prescribed Lipitor to help them lower high cholesterol. It doesn't matter if you are active or thin, young or old, high cholesterol can affect anyone. But you can do something about it; ask your doctor if a cholesterol-lowering drug like Lipitor is right for you. Out of all the cholesterol-lowering medications available, doctors rely on Lipitor most. Learn how the #1 prescribed cholesterol-lowering drug, Lipitor, along with diet and exercise, can lower your cholesterol. To receive valuable information about Lipitor, please click here. |
|
Presentation Speech by Professor Viktor
Mutt of the Karolinska
Institute
Translation from the Swedish text
Your Majesties, Your Royal Highnesses,
Ladies and Gentlemen,
At the meeting of the French Academy of Sciences on August 26, 1816, the chemist
Michel Chevreul suggested that a substance, with fat-like properties, discovered
some decades previously in gallstones by physicians in France and in Germany,
should be named cholesterine, from the Greek: chole, bile, and stereos, solid.
Cholesterin, or cholesterol, as it later came to be called, proved not to be confined to gallstones but to occur also in all organs in humans as in all vertebrates and to be a substance of vital importance for them. It participates in the formation of various cellular membranes and is a substance necessary for the synthesis of bile acids (of importance for digestion) and of the vitally important stereoid hormones. For their elucidation of the complicated structures of cholesterol and of bile acids, Wieland and Windaus were awarded a Nobel Prize in 1928.
Cholesterol is of vital importance but may also be deleterious, and far more so than by causing gallstones. Since the middle of the nineteenth century it has been known that in atherosclerosis, cholesterol, or rather cholesterol esters, accumulate in high concentrations in the lesioned areas of the blood vessels, and since the late 1930s a specific inheritable disease, familial hypercholesterolemia, has been recognized, with greatly increased concentrations of cholesterol in the blood, and severe alterations in the normal structure of blood vessels.
Cholesterol is almost insoluble in water. Its solubility in blood plasma is - like other lipids - due to its being packaged into submicroscopic spherical particles with completely hydrophobic components inside, surrounded outside by a mosaic layer of less hydrophobic ones, such as phospholipids and protein. Such particles are called lipoproteins. Cholesterol occurs mainly in a type of lipoproteins called low density lipoproteins, LDL.
Not all organisms require cholesterol, and some which do so, such as insects, are incapable of producing it by themselves and are, therefore, entirely dependent on dietary sources for it. The mammalian cell, however, is capable of producing its own cholesterol, but it also obtains dietary cholesterol by way of the blood. Schoenheimer's investigations from the 1930s suggested that there was some kind of equilibrium between the amount of cholesterol which the cell itself synthesized and that which it obtained from the diet. How this equilibrium was maintained was, however, completely unknown, as was the cause of the highly increased blood cholesterol concentrations in familial hypercholesterolemia. The complicated mechanism for the cellular synthesis of cholesterol had, however, been elucidated, and investigations in this field by Bloch and by Lynen had in 1964 been recognized by a Nobel Prize.
In elegant and systematic investigations - always in collaboration - the laureates of this year studied cholesterol metabolism in cultures of connective tissue cells from healthy persons and from patients with familial hypercholesterolemia, either without or with the addition of blood serum, and thereby cholesterol, to the culture medium. They made the surprising discovery that whereas cells from healthy persons had on their surfaces specific structures, receptors, for the binding of LDL, cells from the patients had either no such receptors or else decreased numbers of them, depending on whether the patient had acquired the disease from both parents or from only one. Equally surprising was the finding that the LDL, after being bound to the receptor moved together with the latter into the interior of the cell. There, the receptor was set free and returned to the cell surface, where it could again bind LDL. The LDL particle on the other hand disintegrated into its components, and the cholesterol thus released was found to have different functions: it contributed to meeting the requirements of the cell for cholesterol; it decreased the synthesis by the cell of endogenous cholesterol by suppressing the activity of a key enzyme, named HMG CoA reductase, for such synthesis; it decreased the number of LDL receptors and thereby the influx of more LDL; and it activated an enzyme in the cell which converts excessive cholesterol into a suitable storage form. The knowledge thus acquired concerning the normal intracellular metabolism of cholesterol, the "LDL pathway", has given not only insights into the causes of genetically determined rearrangements in cholesterol metabolism where, i.a. various defects in receptor structures have been revealed, but also insights into severe and common disease states where the amount of cholesterol in the diet may play a role. This suggests possibilities for the development of methods for treatment and prevention.
Research on cholesterol has been in continuous progress for two centuries and contains several fascinating chapters by eminent scientists. The chapter that this year's laureates have contributed is one of the most fascinating.
Professor Brown, Professor Goldstein,
In elegant and systematic studies you have discovered a physiological mechanism
of great importance: the way in which mammalian cells strive to establish an
equilibrium between their own synthesis of cholesterol and the cholesterol they
obtain from the circulating blood influenced by diet. You have also elucidated
important genetically determined aberrations from this mechanism.
This knowledge forms a rational basis for development of methods for the treatment and prevention of the widespread disabling diseases known to be a consequence of dearrangement in plasma cholesterol concentrations. You have also demonstrated something else: how successful cooperation can be a principle that should perhaps be more widely applied, both in science and in other areas of human endeavour.
As a representative of the Nobel Assembly of the Karolinska Institute, I convey to you the sincere congratulations of the Assembly and ask you now to receive your Prize from the hands of His Majesty the Ring.
From Nobel Lectures, Physiology or Medicine 1981-1990.
 |
|
|||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.
